Here are relevant reports on : last-mile-delivery-drone-market
-
Drone Logistics and Transportation Market by Platform (Freight, Passenger, Ambulance Drones), Application (Logistics, Transportation), Solution (Hardware, Software, Infrastructure), User, Range, and Region - Global Forecast to 2030
The Drone Logistics And Transportation market is valued at USD 0.9 billion in 2023 and is projected to reach USD 16.1 billion by 2030, at a CAGR of 50.1% from 2023 to 2030. TheMajor players Alphabet Inc. (US), Hardis Group (France), Zipline (US), Volocopter GmbH (Germany), and Textron Inc. (US).
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Anti-Drone Market by Electronic Systems, Kinetic Systems, Laser Systems, Hybrid Systems, Ground-based, Handheld, UAV-based, Detection, Detection & Disruption, Long-range, Medium-range and Short-range - Global Forecast to 2030
The global anti-drone market is expected to grow from USD 4.48 billion in 2025 to USD 14.51 billion by 2030, at a compound annual growth rate (CAGR) of 26.5% during the forecast period. The Key Players RTX (US), Rafael Advanced Defense Systems (Israel), IAI (Israel), Leonardo S.p.A. (Italy), Lockheed Martin Corporation (US), Thales (France), Saab (Sweden), DroneShield Ltd (Australia), and Dedrone (US).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
UAV (Drone) Propulsion Market by Technology (Electric, Thermal, Hybrid), Component (IC Engine (Turbofan, Turboprop, Wankel), Motor, Battery, Fuel Cell, Solar Panel, Propeller, Electronic Speed Controller), Platform, MTOW, Region - Global Forecast to 2030
The UAV (drone) propulsion market is expected to grow from USD 7.0 billion in 2025 to USD 11.3 billion by 2030, at a compound annual growth rate (CAGR) of 10.0% during the forecast period. The Key Players DJI (China), RTX (US), Honeywell International Inc. (US), Rolls-Royce plc (UK), General Electric Company (US), T-motor (China), BRP-Rotax GmbH & Co KG (Austria), Maxon (Germany), General Atomics(US), Epsilor-Electric Fuel Ltd.(Israel), RRC Power Solutions (Germany), EaglePicher Technologies (US), Hobbywing Technology CO., LTD, Yuneec-ATL Drone, and Shenzhen Grepow Battery Co., Ltd. (China).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Nanotechnology Drug Delivery System Market by Type, End-User, Industry, Application and Region - Global Forecast to 2030
The market for drug delivery systems that use nanotechnology to improve the delivery and targeting of medicinal medicines to certain areas within the body is referred to as the nanotechnology drug delivery system market. Drug delivery techniques based on nanotechnology solve problems with conventional approaches, such as low solubility, restricted bioavailability, and lack of specificity, by utilising nanoscale materials and structures.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023
The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Cough Assisted Devices Market by product (Automatic Cough Assist Device, Manual Cough Assist Device), Choice of Delivery (Face Mask, Mouth Piece, Adopter), and End User (Hospitals, Homecare Settings) - Global Forecast to 2023
The global cough assist device market is expected to reach USD 226.5 million by 2023 from USD 150.6 million in 2018, growing at a CAGR of 8.5%. Increasing prevalence of chronic obstructive pulmonary disease (COPD) is the major factor that support the growth of the market. In addition to this, changing lifestyle such as smoking; and rising air pollution are the risk factors that support the growth of the cough assist devices during forecast period. On the other hand, rising awareness regarding advanced treatment method among patient population support the growth of the market. However, availability of alternative treatments is expected to hinder the market to a certain extent.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Emergency Department Information System Market by Delivery Mode (On-Premise, Software as a Service), Software Type (Best-Of-Breed, Enterprise Solutions), Application (CPOE, Patient Tracking & Triage), End User – Global Forecast to 2019
The global emergency department information system (EDIS) market was valued at $312.68 million in 2014 and poised to grow at a CAGR of 15.24% between 2012 and 2019, to reach $635.50 million in 2019. The rapid increase in healthcare expenditure, increasing use of data-driven technologies, implementation of the HITECH Act, and rise in aging population will be the most important growth drivers for this market in the forecast period (2012–2019).
- Published: November 2014
- Price: $ 4950
- TOC Available:
-
Medical Document Management Systems Market by Solution (Document Scanning Software, Document Management Software), Application (Medical Records Management), Mode of Delivery (Web-Based, Cloud-Based), & by End-User (Hospitals) - Global Forecasts to 2019
The global medical document management market is estimated to be worth around $220 million in 2014 and grow at a CAGR of 13%-14% during the forecast period of 2014 to 2019. This market is mainly driven by the need for regulatory compliance, improved patient care and cost containment in healthcare, and accurate, secure, & fast systems to manage critical information. Moreover, the paperless environment created by document management systems results in a streamlined workflow, thus increasing the operational efficiency of healthcare organizations.
- Published: January 2015
- Price: $ 4950
- TOC Available:
-
Route Optimization Software Market by Component (Software & Services), Vertical (On-Demand Food Delivery, Ride Hailing & Taxi Services, Field Services, and Retail & FMCG), Organization Size, Deployment Type, and Region - Global Forecast to 2023
The route optimization software market size is expected to grow from to grow from USD 2.95 billion in 2018 to USD 5.07 billion by 2023, at a CAGR of 11.4% from 2018 to 2023. The major drivers of the route optimization software market include the increasing use of logistics-specific solutions and declining hardware and connectivity costs. Some of the major route optimization software vendors include ALK Technologies (US), AMCS (Ireland), Caliper (US), Descartes (Canada), Esri (US), FLS (Germany), Geoconcept (France), Google (US), Portatour (Austria), Llamasoft (US), Maxoptra (UK), Microlise (UK), Omnitracs (US), Optimoroute (US), ORTEC (Netherlands), Paragon Software (UK), PTV Group (Germany), Quintiq (Netherlands), FarEye (India), Route4me (US), RouteSolutions (US), Routific (Canada), Scientific Logistics (US), Truckstops (UK), Verizon Connect (US), and Workwave (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
